Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	As previously reported	Retroactive application of recapitalization (Note 2)	Preferred Stock	Preferred Stock As previously reported	Preferred Stock Retroactive application of recapitalization (Note 2)	Common Stock	Common Stock As previously reported	Common Stock Retroactive application of recapitalization (Note 2)	Additional Paid-in Capital	Additional Paid-in Capital As previously reported	Additional Paid-in Capital Retroactive application of recapitalization (Note 2)	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit As previously reported	Accumulated Deficit Retroactive application of recapitalization (Note 2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)							1,877,233
Ending balance (in shares) at Dec. 31, 2020				0	16,383,725	(16,383,725)	101,286,645	10,838,010	90,448,635
Ending balance at Dec. 31, 2020	$ (18,225)	$ (18,225)	$ 0	$ 0	$ 62,639	$ (62,639)	$ 10	$ 0	$ 10	$ 68,549	$ 5,920	$ 62,629		$ (86,784)	$ (86,784)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	1,610									1,610
Issuance of common stock upon exercise of stock options (in shares)							171,724
Issuance of common stock upon exercise of stock options	85									85
Unrealized loss on available-for-sale securities	0
Net loss	(11,509)													(11,509)
Ending balance (in shares) at Mar. 31, 2021				0			101,458,369
Ending balance at Mar. 31, 2021	(28,039)			$ 0			$ 10			70,244				(98,293)
Beginning balance (in shares) at Dec. 31, 2020				0	16,383,725	(16,383,725)	101,286,645	10,838,010	90,448,635
Beginning balance at Dec. 31, 2020	(18,225)	$ (18,225)	$ 0	$ 0	$ 62,639	$ (62,639)	$ 10	$ 0	$ 10	68,549	$ 5,920	$ 62,629		(86,784)	$ (86,784)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)							204,119
Beginning balance (in shares) at Dec. 31, 2021				0			155,137,237
Beginning balance at Dec. 31, 2021	168,767			$ 0			$ 16			320,937			$ (391)	(151,795)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	$ 5,340									5,340
Issuance of common stock upon exercise of stock options (in shares)	656,303						656,303
Issuance of common stock upon exercise of stock options	$ 222									222
Issuance of common stock upon vesting of restricted stock units (in shares)							856,917
Taxes related to net share settlement of equity awards (in shares)							(285,533)
Taxes related to net share settlement of equity awards	(1,149)									(1,149)
Unrealized loss on available-for-sale securities	(1,056)												(1,056)
Net loss	(24,881)													(24,881)
Ending balance (in shares) at Mar. 31, 2022				0			156,364,924
Ending balance at Mar. 31, 2022	$ 147,243			$ 0			$ 16			$ 325,350			$ (1,447)	$ (176,676)